本次公开发行情况               发行价（元/股）                                                                                                                                                                                                                                                   8.19       停牌前收盘价（元/股）    9.6 

                               发行市盈率                                                                                                                                                                                                                                                        22.40倍    停牌前总市值（亿元）     10.19

                               定价方式                                                                                                                                                                                                                                                          询价       募集资金总额（亿元）     2.9 

                               是否向战略投资者配售                                                                                                                                                                                                                                              \                                       

财务表现                       营业收入（亿元）                                                                                                                                                                                                                                                  1.37       1.69                     2.25

（2017年-2019年）                                                                                                                                                                                                                                                                                                                        

                               归母净利润（万元）                                                                                                                                                                                                                                                2891.21    4027.93                  5421.16

                               毛利率                                                                                                                                                                                                                                                            66.26%     74.72%                   72.44%

本次募资用途                   大唐药业健康科技产业园区项目、营销体系建设及品牌推广项目和补充流动资金项目                                                                                                                                                                                                                                

主营业务简介                   公司是一家集蒙药资源开发、特色专科药和大健康产品研发、生产和销售为一体的综合性制药企业，公司的主营业务为中成药（含民族药）和化学制剂药的研发、生产和销售。公司目前拥有药品生产许可证、GMP证书和266个药品文号，能够为市场生产和提供符合国家要求的高质量的药品。